Michael M Tarnow - Net Worth and Insider Trading
Michael M Tarnow Net Worth
The estimated net worth of Michael M Tarnow is at least $1 Million dollars as of 2024-11-13. Michael M Tarnow is the Director of Xenon Pharmaceuticals Inc and owns about 31,865 shares of Xenon Pharmaceuticals Inc (XENE) stock worth over $1 Million. Details can be seen in Michael M Tarnow's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael M Tarnow has not made any transactions after 2014-11-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael M Tarnow
Michael M Tarnow Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael M Tarnow owns 2 companies in total, including Xenon Pharmaceuticals Inc (XENE) , and CASI Pharmaceuticals Inc (CASI) .
Click here to see the complete history of Michael M Tarnow’s form 4 insider trades.
Insider Ownership Summary of Michael M Tarnow
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc | 2019-05-21 | director |
| CASI | CASI Pharmaceuticals Inc | 2012-01-23 | director |
Michael M Tarnow Latest Holdings Summary
Michael M Tarnow currently owns a total of 1 stock. Michael M Tarnow owns 31,865 shares of Xenon Pharmaceuticals Inc (XENE) as of November 4, 2014, with a value of $1 Million.
Latest Holdings of Michael M Tarnow
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc | 2014-11-04 | 31,865 | 43.36 | 1,381,666 |
Holding Weightings of Michael M Tarnow
Michael M Tarnow Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael M Tarnow has made a total of 0 transactions in Xenon Pharmaceuticals Inc (XENE) over the past 5 years. The most-recent trade in Xenon Pharmaceuticals Inc is the sale of 0 shares on November 4, 2014, which brought Michael M Tarnow around $0.
Insider Trading History of Michael M Tarnow
- 1
Michael M Tarnow Trading Performance
Michael M Tarnow Ownership Network
Ownership Network List of Michael M Tarnow
Ownership Network Relation of Michael M Tarnow
Michael M Tarnow Owned Company Details
What does Xenon Pharmaceuticals Inc do?
Who are the key executives at Xenon Pharmaceuticals Inc?
Michael M Tarnow is the director of Xenon Pharmaceuticals Inc. Other key executives at Xenon Pharmaceuticals Inc include SVP Bus. & Corp. Development Sherrington Robin , director & PRESIDENT & CEO Ian Mortimer , and Chief Medical Officer Christopher John Kenney .
Xenon Pharmaceuticals Inc (XENE) Insider Trades Summary
Over the past 18 months, Michael M Tarnow made no insider transaction in Xenon Pharmaceuticals Inc (XENE). Other recent insider transactions involving Xenon Pharmaceuticals Inc (XENE) include a net sale of 26,576 shares made by Gary Patou , a net sale of 131,245 shares made by Simon N. Pimstone , and a net sale of 31,655 shares made by Ian Mortimer .
In summary, during the past 3 months, insiders sold 0 shares of Xenon Pharmaceuticals Inc (XENE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 236,705 shares of Xenon Pharmaceuticals Inc (XENE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 236,705 shares.
Xenon Pharmaceuticals Inc (XENE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xenon Pharmaceuticals Inc Insider Transactions
Michael M Tarnow Mailing Address
Above is the net worth, insider trading, and ownership report for Michael M Tarnow. Currently GuruFocus does not have mailing address information for Michael M Tarnow.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
